Default company panoramic image

Carbotix LLC

Innovative, biodegradable, organic-polymer based medical products that reduce infection (antimicrobial) and enhance recovery.

  • Stage Concept Only
  • Industry Medical Devices and Equipment
  • Location St. Louis, MO, USA
  • Currency USD

Company Summary

The rising incidence of antibiotic-resistant microbes represents a "ticking time bomb" as threatening as climate change. The cost is >$30 billion in the U.S. alone; multiply WW. Our product kills the toughest strains, including MRSA, and prevents microbe reentry, while simultaneously speeding/enhance recovery. Also directed to fungal and acne treatment. Customers are healthcare providers worldwide, as well as military, veterinary and OTC.


  • Default avatar
    Larry Kaplan
    Chief Executive Officer

    Seasoned senior executive with successful track record in complex global business, technology and regulatory environments, with IPO and going-private experience. CEO of Eudora Global and former CEO of NAVTEQ (a $1B+ revenue company purchased by Nokia for $8.1B).

  • Default avatar
    Randy Delkus

    Versatile senior executive with extensive experience in the healthcare field, including operations, sales, marketing, start-ups and turn-arounds. CEO of Citizens Rx (pharmacy benefits manager), co-founder of Eudora Global, former CEO of The Cedars at the JCA (a full CCRC in St. Louis), and former President & CEO of AAQ and The Incubation Factory.

  • Default avatar
    Todd Thomason
    Chief Financial Officer

    More than 20 years of experience in healthcare, investment banking, and as CFO serving public and private companies. Former senior member of M&A Group of Express Scripts and former board member of Accentia Biopharmaceutical.

  • Default avatar
    Steve Regester
    EVP Business Development & Strategy

    A medical device business development and distribution expert with 30 years experience across medical manufacturing and distribution companies. Experience at companies such as Johnson & Johnson, Ethicon Endo Surgery, Baxter Labs, Terumo, Boston Scientific, Neoprobe, OnQ, Nexus and Medivance. Specialized in emerging technology and devices with companies offering innovative medical and surgical products that are new to the marketplace.

  • Default avatar
    David Shaw
    VP Business Development & Distribution

    Accomplished executive with a career spanning more than 20 years in sales and management in the medical device industry. Experience at companies like Boston Scientific, Medtronic, and Smith and Nephew Endoscopy. Has built three start-up companies including, most recently, Surgioscopy, a medical device sales and marketing distribution network. Distribution relationships in U.S. and across the globe.

Previous Investors

  • Default avatar
    Referred to STL Arch Angels by Cory Spielberg